Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pro-Dex Inc. | 16 | 0 | 0 | 0 | €16.70 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.06 | €100.00 | 49.120% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €36.60 | €46.08 | 25.908% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.23 | €3.70 | 201.058% |
| Merck & Co. Inc. | 28 | 1 | 4 | 0 | €122.60 | €124.93 | 1.900% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €13.77 | €23.46 | 70.399% |
| Medtronic plc | 10 | 1 | 0 | 0 | €74.52 | €94.38 | 26.651% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €203.60 | €204.50 | 0.442% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €37.57 | €48.50 | 29.092% |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.48 | €4.00 | 61.290% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 1 | 0 | €1.63 | €4.39 | 169.240% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.00 | €11.00 | 83.456% |
| UCB S.A. | 2 | 0 | 0 | 0 | €124.95 | - | - |
| Cigna Corp. | 15 | 0 | 1 | 0 | €331.15 | €342.03 | 3.285% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €29.15 | €35.99 | 23.449% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €371.40 | €382.71 | 3.044% |
| Bausch Health Companies Inc. | 4 | 0 | 2 | 0 | €8.15 | €16.47 | 102.263% |
| US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €95.50 | €108.77 | 13.894% |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €80.77 | €88.14 | 9.122% |
| GSK plc | 1 | 0 | 0 | 0 | €19.25 | - | - |
| Patterson Companies Inc. | 6 | 0 | 0 | 0 | €24.20 | €32.18 | 32.984% |